U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07572890) titled 'Adia Med of Winter Park LLC Chronic Kidney Disease Research Study' on May 01.
Brief Summary: The goal of this clinical trial is to learn whether a new regenerative treatment called AdiaVita, made from umbilical cord blood-derived stem cells and exosomes combined with glutathione, is safe and can help improve kidney function in adults with chronic kidney disease (CKD). In this condition, the kidneys gradually lose their ability to filter blood as well as they should. The main questions it aims to answer are whether AdiaVita plus glutathione improves kidney function better than control treatments, as measured by blood tests for estimate...